IBDEI119 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16607,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,16607,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,16607,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,16608,0)
 ;;=D68.0^^88^879^199
 ;;^UTILITY(U,$J,358.3,16608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16608,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,16608,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,16608,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,16609,0)
 ;;=C88.0^^88^879^200
 ;;^UTILITY(U,$J,358.3,16609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16609,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,16609,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,16609,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,16610,0)
 ;;=C91.02^^88^879^3
 ;;^UTILITY(U,$J,358.3,16610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16610,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,16610,1,4,0)
 ;;=4^C91.02
 ;;^UTILITY(U,$J,358.3,16610,2)
 ;;=^5001764
 ;;^UTILITY(U,$J,358.3,16611,0)
 ;;=C92.02^^88^879^6
 ;;^UTILITY(U,$J,358.3,16611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16611,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,16611,1,4,0)
 ;;=4^C92.02
 ;;^UTILITY(U,$J,358.3,16611,2)
 ;;=^5001791
 ;;^UTILITY(U,$J,358.3,16612,0)
 ;;=D09.3^^88^879^46
 ;;^UTILITY(U,$J,358.3,16612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16612,1,3,0)
 ;;=3^Carcinoma in Situ of Thyroid/Oth Endocrine Glands
 ;;^UTILITY(U,$J,358.3,16612,1,4,0)
 ;;=4^D09.3
 ;;^UTILITY(U,$J,358.3,16612,2)
 ;;=^5001955
 ;;^UTILITY(U,$J,358.3,16613,0)
 ;;=C22.0^^88^879^87
 ;;^UTILITY(U,$J,358.3,16613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16613,1,3,0)
 ;;=3^Hepatocellular Carcinoma
 ;;^UTILITY(U,$J,358.3,16613,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,16613,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,16614,0)
 ;;=C24.9^^88^879^114
 ;;^UTILITY(U,$J,358.3,16614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16614,1,3,0)
 ;;=3^Malig Neop Biliary Tract,Unspec
 ;;^UTILITY(U,$J,358.3,16614,1,4,0)
 ;;=4^C24.9
 ;;^UTILITY(U,$J,358.3,16614,2)
 ;;=^5000942
 ;;^UTILITY(U,$J,358.3,16615,0)
 ;;=C50.922^^88^879^138
 ;;^UTILITY(U,$J,358.3,16615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16615,1,3,0)
 ;;=3^Malig Neop Left Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,16615,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,16615,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,16616,0)
 ;;=C34.91^^88^879^156
 ;;^UTILITY(U,$J,358.3,16616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16616,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung,Unspec Part
 ;;^UTILITY(U,$J,358.3,16616,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,16616,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,16617,0)
 ;;=C50.921^^88^879^160
 ;;^UTILITY(U,$J,358.3,16617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16617,1,3,0)
 ;;=3^Malig Neop Right Male Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,16617,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,16617,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,16618,0)
 ;;=C90.02^^88^879^172
 ;;^UTILITY(U,$J,358.3,16618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16618,1,3,0)
 ;;=3^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,16618,1,4,0)
 ;;=4^C90.02
 ;;^UTILITY(U,$J,358.3,16618,2)
 ;;=^5001753
 ;;^UTILITY(U,$J,358.3,16619,0)
 ;;=D51.9^^88^879^25
 ;;^UTILITY(U,$J,358.3,16619,1,0)
 ;;=^358.31IA^4^2
